ACON Labs

11/03/2025

We are excited to announce our new Flowflex Plus 4-in-1 test - the first of its kind! This new product is for testing RSV, Flu A and B and COVID.

11/26/2024

We wish you a Happy Thanksgiving holiday.

03/26/2024

01/02/2024

ACON Laboratories would like to wish everyone a Happy New Year!

11/30/2023

ACON Laboratories Receives FDA 510(k) Clearance for Flowflex COVID-19 Tests.

02/03/2022

ACON Laboratories, Inc. is the only legal manufacturer of the FDA EUA Flowflex COVID-19 Antigen Home Test.

The Flowflex™ COVID-19 Antigen Home Test is all you need to determine your family’s Covid-19 status, whether symptoms are present or not. Can be used on children as young as 2 years old. Get the convenience of Flowflex!

Easy and Affordable
Highly Accurate Nasal Swab Test
Quick Results in 15 minutes
Safe for children as young as 2 years old
For use with and without symptoms

07/26/2021

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.

06/29/2021

Nonlinear eGFR decline more likely for African Caribbean adults with type 2 diabetes
African Caribbean adults and those with a high HbA1c are more likely to have a nonlinear decline in kidney function that increases progression of end-stage renal disease in type 2 diabetes, according to study data.

African Caribbean adults and those with a high HbA1c are more likely to have a nonlinear decline in kidney function that increases progression of end-stage renal disease in type 2 diabetes, according to study data. “We studied an ethnically diverse cohort with nearly half of our patients being...

06/28/2021

Cases of type 2 diabetes among children more than doubled during the coronavirus pandemic, research finds

Cases of type 2 diabetes among children more than doubled during the coronavirus pandemic at one Louisiana hospital, according to research presented Friday. The researchers say the cases increased in severity, too.

06/25/2021

While there is discussion around diabetes-induced stress, this trial looks at the inverse – how stress levels can impact an individual’s diabetes management (as measured by changes in a person’s A1C).

This clinical trial is currently recruiting – participants will be enrolled in one of two stress-intervention courses to measures changes in A1C, diabetes distress, and more.